Llwytho...
Tiotropium in chronic obstructive pulmonary disease – a review of clinical development
BACKGROUND: Bronchodilators are the mainstay of pharmacological treatment in chronic obstructive pulmonary disease (COPD), and long-acting muscarinic antagonist (LAMA) monotherapy is recommended as initial treatment for Global Initiative for Chronic Obstructive Lung Disease (GOLD) groups B, C, and D...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Respir Res |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7389564/ https://ncbi.nlm.nih.gov/pubmed/32727455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01407-y |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|